Turkey Diabetes Therapeutics Market Analysis

Turkey Diabetes Therapeutics Market Analysis

$ 3999

Turkey's diabetes therapeutics market is expected to witness growth from $1.1 Bn in 2022 to $2.5 Bn in 2030 with a CAGR of 10.2% for the forecasted year 2022-30. The rising awareness about diabetes and the supportive government policies to promote diabetes in Turkey are the major market drivers. The Turkey diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Nobel İlaç, Koçak Farma, and GlaxoSmithKline are the major players in the Turkey diabetes therapeutics market.

ID: IN10TRPH036 CATEGORY: Pharmaceuticals GEOGRAPHY: Turkey AUTHOR: Dr. Parul Choudhary

Buy Now

Turkey Diabetes Therapeutics Market Executive Analysis

Turkey's diabetes therapeutics market is at around $1.1 Bn in 2022 and is projected to reach $2.5 Bn in 2030, exhibiting a CAGR of 10.2% during the forecast period. In the 2023 budget, the Turkish Ministry of Health increased the funds allotted for preventative health care by eight times, totaling $1.78 Bn. Additionally, it was mentioned that hospitals outfitted with the most cutting-edge equipment are being placed into operation one at a time, and the Ministry offers services through more than 14,000 healthcare facilities, including 953 hospitals and 8,000 family health centers.

With more than six Mn individuals, Turkey has the third-largest diabetes population in the world and the largest in Europe. The International Diabetes Federation (IDF) reports that the prevalence rate varies between 11 and 14 % of the population, but that the proportion of people without a diabetes diagnosis is 38%. A hormone called insulin aids in controlling the body's blood sugar levels. People with type 1 and type 2 diabetes who need to take insulin to control their blood sugar levels frequently utilize this medication. Biguanides, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter-2 (SGLT2) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists are a few of the kinds of oral drugs used to treat type 2 diabetes. GLP-1 receptor agonists and amylin mimetics are two injectable drugs that help persons with type 2 diabetes control their blood sugar levels.

Turkey Diabetes Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

Turkey is experiencing a rise in diabetes awareness, which is projected to increase the demand for diabetic medicines. Government agencies and healthcare professionals are attempting to inform the public about the value of diabetes control and early identification. With a focus on enhancing access to healthcare services and managing chronic diseases like diabetes, the Turkish government has been expanding its healthcare spending in recent years. The Turkey diabetes therapeutics market is anticipated to grow as a result of this rise in healthcare spending.

Market Restraints

Although the Turkish government has been spending more money on healthcare, access to services is still restricted in some places, especially in rural areas. By reducing the number of people who have access to diabetic medicines, this limited healthcare access may impede market expansion. The high prevalence of diabetes in Turkey may be influenced by cultural and lifestyle elements like the country's high obesity rate and unhealthful diet habits. These elements may also reduce the efficacy of diabetes treatments and restrain market expansion. The approval and adoption of new diabetes medicines could be slowed or delayed by the complexity of the Turkish pharmaceutical regulatory environment. As a result, there may be fewer newer therapies available, which could slow Turkey's diabetes therapeutics market expansion.

Competitive Landscape

Key Players

  • Abdi İbrahim (TUR)
  • Deva Holding (TUR)
  • İlko İlaç (TUR)
  • Nobel İlaç (TUR)
  • Koçak Farma (TUR)
  • Glaxosmithkline
  • Johnson Johnson
  • Merck
  • Novartis
  • Novo Nordisk
  • Sanofi
  • Takeda Pharmaceutical

Healthcare Policies and Regulatory Landscape

The primary regulating and accountable body for medications, biologicals, and medical devices in Turkey is the Ministry of Health (the "Ministry"). Pharmaceutical items cannot be introduced to the market without first receiving a license from the Ministry. A request for a license must be made to the Ministry along with the supporting documentation outlined in the Licensing Regulation on Medicinal Products. The applicant must carry out clinical trials, toxicological and pharmacological investigations, and more before filing a licensing application. The process for carrying out clinical trials is described in the Regulation on Clinical Research. A clinical trial dossier must be submitted concurrently to the Turkish Medicines and Medical Devices Agency (TTCK) and the Ethics Committee (designated by the Ministry) as the first step in the application process.

To ensure that medical items are made available to customers on fair terms and to promote a more effective and long-lasting healthcare system, the Ministry of Health establishes the maximum prices and applies pricing measures. Turkish pharmaceutical costs are based on reference prices from five reference countries, all of which are members of the European Union, as defined by the Ministry of Health. The lowest warehouse sales price for authentic and authorized goods (excluding discounts) in the reference nations is referred to as the reference price. The lower price shall be taken into account as the reference price if, however, the country where the product is produced or imported is not one of the reference countries but the warehouse sales price of the pertinent product is less than the reference prices in the reference countries.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Diabetes Therapeutics Segmentation

By Type (Revenue, USD Billion):

  • Diabetes 1
  • Diabetes 2

By Application (Revenue, USD Billion):

  • Preventive
    • Prediabetes
    • Nutrition
    • Obesity
    • Lifestyle Management
  •  Treatment/Care
    • Diabetes
    • Smoking Cessation
    • Musculoskeletal Disorders
    • Central Nervous System Disorders
    • Cardiovascular Disease
    • Medication Adherence
    • Chronic Respiratory Disorders
    • Gastrointestinal Disorders
    • Rehabilitation
    • Substance Use Disorders & Addiction Management

By Drug (Revenue, USD Billion):

  • Oral Anti-diabetic Drugs
  • Insulin
  • Non-insulin Injectable Drug
  • Combination Drug

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Subcutaneous
  • Intravenous

By Distribution Channel (Revenue, USD Billion):

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Nobel İlaç, Koçak Farma, and GlaxoSmithKline are the major players in the Turkey diabetes therapeutics market.

The Turkey diabetes therapeutics market is expected to grow from $1.1 Bn in 2022 to $2.5 Bn in 2030 with a CAGR of 10.2% for the forecasted year 2022-2030.

The Turkey diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 12 February 2024
Updated by: Ritu Baliya

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter